CNY 25.67
(-0.62%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 6.5 Billion CNY | 4.72% |
2022 | 5.83 Billion CNY | 23.45% |
2021 | 4.72 Billion CNY | 25.01% |
2020 | 3.78 Billion CNY | 20.22% |
2019 | 3.14 Billion CNY | 42.89% |
2018 | 2.2 Billion CNY | 44.68% |
2017 | 1.52 Billion CNY | 27.2% |
2016 | 1.19 Billion CNY | 33.33% |
2015 | 896.87 Million CNY | 28.22% |
2014 | 699.48 Million CNY | 24.12% |
2013 | 563.56 Million CNY | 17.26% |
2012 | 480.61 Million CNY | 31.26% |
2011 | 366.14 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.69 Billion CNY | -2.34% |
2024 Q3 | 1.77 Billion CNY | 5.98% |
2024 Q1 | 1.73 Billion CNY | 4.78% |
2023 Q2 | 1.66 Billion CNY | 6.31% |
2023 Q1 | 1.56 Billion CNY | -7.73% |
2023 FY | 6.1 Billion CNY | 4.72% |
2023 Q4 | 1.65 Billion CNY | 7.74% |
2023 Q3 | 1.53 Billion CNY | -7.61% |
2022 Q4 | 1.69 Billion CNY | 13.83% |
2022 Q3 | 1.48 Billion CNY | 6.14% |
2022 Q2 | 1.4 Billion CNY | 11.88% |
2022 Q1 | 1.25 Billion CNY | -6.77% |
2022 FY | 5.83 Billion CNY | 23.45% |
2021 Q2 | 1.11 Billion CNY | 3.39% |
2021 FY | 4.72 Billion CNY | 25.01% |
2021 Q1 | 1.07 Billion CNY | -2.6% |
2021 Q3 | 1.18 Billion CNY | 6.33% |
2021 Q4 | 1.34 Billion CNY | 13.2% |
2020 Q2 | 872.72 Million CNY | 1.43% |
2020 Q3 | 938.81 Million CNY | 7.57% |
2020 Q4 | 1.1 Billion CNY | 18.06% |
2020 FY | 3.78 Billion CNY | 20.22% |
2020 Q1 | 860.44 Million CNY | -4.52% |
2019 Q4 | 901.2 Million CNY | 17.57% |
2019 Q1 | 734.55 Million CNY | 3.05% |
2019 FY | 3.14 Billion CNY | 42.89% |
2019 Q2 | 742.26 Million CNY | 1.05% |
2019 Q3 | 766.53 Million CNY | 3.27% |
2018 Q4 | 712.79 Million CNY | 28.67% |
2018 FY | 2.2 Billion CNY | 44.68% |
2018 Q3 | 553.96 Million CNY | 15.82% |
2018 Q2 | 478.31 Million CNY | 6.53% |
2018 Q1 | 448.99 Million CNY | 6.66% |
2017 FY | 1.52 Billion CNY | 27.2% |
2017 Q1 | 341.9 Million CNY | -1.11% |
2017 Q2 | 360.85 Million CNY | 5.54% |
2017 Q3 | 397.36 Million CNY | 10.12% |
2017 Q4 | 420.97 Million CNY | 5.94% |
2016 Q2 | 283.57 Million CNY | 9.14% |
2016 Q3 | 306.66 Million CNY | 8.14% |
2016 Q4 | 345.72 Million CNY | 12.74% |
2016 FY | 1.19 Billion CNY | 33.33% |
2016 Q1 | 259.84 Million CNY | -0.23% |
2015 Q4 | 260.43 Million CNY | 16.86% |
2015 Q3 | 222.85 Million CNY | 4.3% |
2015 Q2 | 213.67 Million CNY | 6.89% |
2015 Q1 | 199.9 Million CNY | 3.65% |
2015 FY | 896.87 Million CNY | 28.22% |
2014 Q1 | 155.96 Million CNY | 0.0% |
2014 FY | 699.48 Million CNY | 24.12% |
2014 Q4 | 192.86 Million CNY | 6.0% |
2014 Q3 | 181.94 Million CNY | 7.86% |
2014 Q2 | 168.69 Million CNY | 8.16% |
2013 FY | 563.56 Million CNY | 17.26% |
2012 FY | 480.61 Million CNY | 31.26% |
2011 FY | 366.14 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Shanghai No.1 Pharmacy Co., Ltd. | 281.4 Million CNY | -2211.014% |
Jointown Pharmaceutical Group Co., Ltd | 9.08 Billion CNY | 28.443% |
LBX Pharmacy Chain Joint Stock Company | 5.88 Billion CNY | -10.56% |
Yunnan Jianzhijia Health-Chain Co., Ltd. | 2.73 Billion CNY | -137.704% |